2023 annual financial data
Arcturus Therapeutics Holdings 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -11.47%.
Operating income was -78,205,000 USD and net income was -29,725,000 USD.
Operating cash flow was -18,099,000 USD.
Get free Arcturus Therapeutics Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 157,748,000 USD
- Operating income
- -78,205,000 USD
- Net income
- -29,725,000 USD
- Operating cash flow
- -18,099,000 USD